| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |